Overview

Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer

Status:
Completed

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to confirm the Efficacy,the Safety and the Quality of Life after TOOKAD® Soluble VTP in localized prostate cancer patients.

Phase:

Phase 3

Details

Lead Sponsor:

Steba Biotech S.A.